Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine.
Pooja Gokhale, PharmD
Advertisement
Articles by Pooja Gokhale, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Clinician Shortages, Access Gaps Challenge Rural Primary Care
3
Diet, Lifestyle Come Into Focus for Managing Multiple Sclerosis: Rebecca Spain, MD
4
Guselkumab Shows Sustained 48-Week Protection Against Joint Damage in PsA
5
